EU-IN_VITRO_MEDICAL_DEVICE_REG-ART_5_2_ANX_1

In Vitro Diagnostic Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Art. 5(2) and Annex I of Regulation (EU) 2017/746 on In Vitro Diagnostic Medical Devices, 5 May 2017, as corrected 27 December 2019

This list contains a non-exhaustive inventory of hazardous substances for purposes of Regulation (EU) 2017/746, including Chap. 2 (Placing on the market and putting into service) and Annex I (General Safety and Performance Requirements). It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).

RELEVANT LEGISLATION
Back to the List

Residues (coal tar), anthracene oil distn.; Anthracene Oil Fraction [The residue from the fraction distillation of crude anthracene boiling in the approximate range of 340 °C to 400 °C (644°F to 752°F). It consists predominantly of tri-and polynuclear aromatic and heterocyclic hydrocarbons.]

The residue from the fraction distillation of crude anthracene boiling in the approximate range of 340°C to 400°C (644°F to 752°F). It consists predominantly of tri- and polynuclear aromatic and heterocyclic hydrocarbons. EC / List no: 295-505-8 CAS no: 92061-92-2
EU CLP (1272/2008)
Carc. 1B; Muta. 1B